FTC sues key pharmacy profit administrators around insulin selling prices The agency brought motion against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record price of lifestyle-preserving insulin medication. This approach aligns with These attempts, the ONC claimed. The marketplace is tackling https://eduardoqiyne.jiliblog.com/87864563/rumored-buzz-on-healthcare-news